Answers are grounded in this paper and cite their sources.
Osteochondral defects are difficult to repair due to the absence of blood vessels and poor self-healing ability of cartilage. Although mesenchymal stem cells (MSCs) have multipotent differentiation potential, their directional differentiation is uncontrollable and survival rates after injection are low. This paper aims to clarify the mechanisms and material strategies of MSCs in bone and joint remodeling, reviewing the signaling pathways and transcription factor regulation of osteogenic and chondrogenic differentiation, as well as research progress on genetically modified stem cells combined with hydrogel scaffolds for bone defect repair. The results show that osteogenic differentiation converges on core transcription factors such as RUNX2; Gene modification can enhance the directed differentiation and paracrine effects of stem cells; hydrogels achieve three-dimensional support and fixed-site residence through in situ gelation; biomimetic scaffolds combine mechanical support with osteogenic-angiogenic coupling. This collaborative strategy of "signal regulation—gene modification—material delivery" offers feasible ideas for bone and joint repair, but matching material degradation and regeneration rhythms, as well as the long-term safety of gene modification, still need to be verified. Future focus can be on intelligent response stents and clinical translation.
No takes yet. Share an insight, caveat, or question.
Yihao Chen (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: